Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Tak

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
Nuclear Medicine Communications|October 1, 1993
99Tcm-labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritisM H de Bois, J W Arndt, P P Tak, et al.
Arthritis and Rheumatism|March 23, 2000
Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritidesI M van der Heijden, B Wilbrink, I Tchetverikov, et al.
Scandinavian Journal of Immunology|October 1, 1993
A subset of V delta 1+ T cells proliferates in response to Epstein-Barr virus-transformed B cell lines in vitroD L Orsini, P C Res, J M Van Laar, et al.
Annals of the Rheumatic Diseases|November 29, 2007
Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patientsT C van der Pouw Kraan, C A Wijbrandts, L G van Baarsen, et al.
Annals of the Rheumatic Diseases|October 16, 2004
Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritisG J Wolbink, A E Voskuyl, W F Lems, et al.
Arthritis and Rheumatism|January 1, 2008
Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose studyP P Tak, R M Thurlings, C Rossier, et al.
Annals of the Rheumatic Diseases|August 30, 2008
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritisC A Wijbrandts, S I van Leuven, H D Boom, et al.
Arthritis and Rheumatism|July 1, 1996
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritisP P Tak, P C Taylor, F C Breedveld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritisM M Maurice, A C Lankester, A C Bezemer, et al.
Rheumatology (Oxford, England)|October 30, 2007
Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammationC E Vergunst, D M Gerlag, H Dinant, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Nuclear Medicine Communications|October 1, 1993
99Tcm-labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritisM H de Bois, J W Arndt, P P Tak, et al.
Arthritis and Rheumatism|March 23, 2000
Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritidesI M van der Heijden, B Wilbrink, I Tchetverikov, et al.
Scandinavian Journal of Immunology|October 1, 1993
A subset of V delta 1+ T cells proliferates in response to Epstein-Barr virus-transformed B cell lines in vitroD L Orsini, P C Res, J M Van Laar, et al.
Annals of the Rheumatic Diseases|November 29, 2007
Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patientsT C van der Pouw Kraan, C A Wijbrandts, L G van Baarsen, et al.
Annals of the Rheumatic Diseases|October 16, 2004
Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritisG J Wolbink, A E Voskuyl, W F Lems, et al.
Arthritis and Rheumatism|January 1, 2008
Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose studyP P Tak, R M Thurlings, C Rossier, et al.
Annals of the Rheumatic Diseases|August 30, 2008
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritisC A Wijbrandts, S I van Leuven, H D Boom, et al.
Arthritis and Rheumatism|July 1, 1996
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritisP P Tak, P C Taylor, F C Breedveld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritisM M Maurice, A C Lankester, A C Bezemer, et al.
Rheumatology (Oxford, England)|October 30, 2007
Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammationC E Vergunst, D M Gerlag, H Dinant, et al.
Pageof 21